Anti-angiogenesis treatment with thalidomide in endometriosis: A pilot study

In: Fertility and Sterility · 2002 · vol. 78 , pp. S87 · doi:10.1016/s0015-0282(02)03609-9 · W2038452377
OA: closed CC0 ⤵ 19 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This pilot study investigated the efficacy of thalidomide as an anti-angiogenic treatment for endometriosis by assessing its impact on disease severity and patient symptoms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (20)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK